Original Research

Glibenclamide in patients with poorly controlled type 2 diabetes: a 12-week, prospective, single-center, open-label, dose-escalation study

Rambiritch V, Maharaj B, Naidoo P

Clinical Pharmacology: Advances and Applications 2014, 6:63-69

Published Date: 4 April 2014